EMT in cervical cancer: Its role in tumour progression and response to therapy

被引：247

作者：

Qureshi, Rehana ^{[1
]}

Arora, Himanshu ^{[2
]}

Rizvi, M. A. ^{[1
]}

机构：

[1] Jamia Millia Islamia, Dept Biosci, Genome Biol Lab, New Delhi 110025, India

[2] Univ Strasbourg, ESBS API Pole, CNRS, IREBS UMR7242, F-67412 Illkirch Graffenstaden, France

来源：

CANCER LETTERS | 2015年 / 356卷 / 02期

关键词：

Epithelial Mesenchymal Transition; Mesenchymal transition (EMT); Therapeutics; Oncogene; Tumour-suppressor; Cervical cancer; EPITHELIAL-MESENCHYMAL TRANSITION; ASTROCYTE-ELEVATED GENE-1; NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; LYMPH-NODE METASTASIS; FUSED TOES HOMOLOG; CELL-MIGRATION; E-CADHERIN; DOWN-REGULATION; MIR-200; FAMILY;

D O I：

10.1016/j.canlet.2014.09.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The prognosis of cervical patients significantly decreases as the cancer metastasizes to other parts of the body. The epithelial to mesenchymal transition (EMT) plays an important role in cervical cancer progression and metastasis. Recurrence is the primary cause of the increased number of deaths due to cervical cancer. Oncogenes, such as AEG1, Sam-68, FTS and miR-361-5p, induce EMT in cervical cancer. Tumour suppressors, such as LMX-1, SFRP1, klotho, and miR-155, suppress EMT in cervical cancer. Factors such as hypoxia, the radiation dose, cytokines, proteins, transcription factors, and signalling pathways also play an important role in the induction, progression and maintenance of EMT in cervical cancer. Overall, this review describes a wide range of factors with potential roles in EMT that have been identified to date, and this information could be important for the development of new and more effective therapeutics that ameliorate the negative impact of cervical pathogenesis via EMT. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

引用

页码：321 / 331

页数：11

共 50 条

[1] Role of gangliosides in tumour progression: A molecular target for cancer therapy?
Fish, RG
MEDICAL HYPOTHESES, 1996, 46 (02) : 140 - 144
[2] Role of macrophages in tumour progression and therapy
Lewis, C. E.
BONE, 2011, 48 (01) : S8 - S8
[3] Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy
Abou-Faycal, Cherine
Hatat, Anne-Sophie
Gazzeri, Sylvie
Eymin, Beatrice
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (02)
[4] Role of NADPH oxidase and its therapeutic intervention in TGF-β-mediated EMT progression: an in vitro analysis on HeLa cervical cancer cells
Karthika Muthuramalingam
Moonjae Cho
Youngmee Kim
Applied Biological Chemistry, 2020, 63
[5] Role of NAPDH oxidase and its therapeutic intervention in TGF-β-mediated EMT progression: an in vitro analysis on HeLa cervical cancer cells
Muthuramalingam, Karthika
Cho, Moonjae
Kim, Youngmee
APPLIED BIOLOGICAL CHEMISTRY, 2020, 63 (01)
[6] SPARC in cancer biology: Its role in cancer progression and potential for therapy
Tai, Isabella T.
Tang, Michelle J.
DRUG RESISTANCE UPDATES, 2008, 11 (06) : 231 - 246
[7] Correction to: Role of NADPH oxidase and its therapeutic intervention in TGF-β-mediated EMT progression: an in vitro analysis on HeLa cervical cancer cells
Karthika Muthuramalingam
Moonjae Cho
Youngmee Kim
Applied Biological Chemistry, 2021, 64
[8] The role of exosomes in colorectal cancer disease progression and response to therapy
Bracci, Laura
Lozupone, Francesco
Parolini, Isabella
CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 51 : 84 - 91
[9] The role of cytochrome P450 in tumour development and progression and its potential in therapy
Murray, GI
JOURNAL OF PATHOLOGY, 2000, 192 (04): : 419 - 426
[10] The role of angiogenesis in tumour progression of breast cancer
Gasparini, MDG
BREAST CANCER - ADVANCES IN BIOLOGY AND THERAPEUTICS, 1996, : 167 - 173

← 1 2 3 4 5 →